No profile data available.
Kezar Life Sciences, Inc. (KZR) is a healthcare company in the autoimmune treatment pharmaceuticals industry, based in South San Francisco, United States, with about 9 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$56.03 million. Its market capitalization was $53.86 million.
Figures from company filings and market data; latest fiscal year ended December 31, 2025.
, a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.
Kezar Life Sciences reported $0 in revenue for fiscal year 2025.
$53.86 million.
Listed companies of a similar size in the same industry (autoimmune treatment pharmaceuticals) include Cue Biopharma, Inc. (CUE), Nkarta, Inc. (NKTX), Immunic, Inc. (IMUX), Adicet Bio, Inc. (ACET).